Search clinical trials for: Tumor Response

Total 44935 results

Jiangxi Provincial Cancer Hospital

Recruiting

High- and Low-dose Radiotherapy Combined With Envafolimab for Metastatic Solid Tumor (ST-CR01)

Metastatic Cancer

China
The First Affiliated Hospital of Nanchang University
Shanghai Dengding BioAI Co.

Recruiting

Using Neoantigen Peptide Vaccine/Neoantigen-based DC to Treat Advanced Malignant Solid Tumors

Advanced Malignant Solid Tumors

China
Peking Union Medical College Hospital

Recruiting

Radiographic Response to Chemotherapy in Unresected Localized Pancreatic Cancer

Pancreatic Cancer | Ultrasonography | First-line Chemotherapy

China
NHS Greater Glasgow and Clyde

Recruiting

Advances in Imaging to Assess Response in Pancreatic Cancer (AIR-PANC) (AIR-PANC)

Pancreatic Ductal Adenocarcinoma

United Kingdom
Duke University
Personalis Inc.

Recruiting

GRETeL: Tumor Response to Standard Radiotherapy and TMZ Patients With GBM

Glioblastoma | Glioma, Malignant

United States
Immunophotonics, Inc.

Recruiting

Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS (INJECTABL-1)

Soft Tissue Sarcoma | Nonsmall Cell Lung Cancer | Metastatic Solid Tumor | Colon Cancer

France, United Kingdom, United States, Germany, Switzerland
Centre Leon Berard

Recruiting

Multiparametric Quantitative MRI and Response to Neoadjuvant Radiotherapy for Soft-tissue Sarcoma (SarQuantIRM)

Soft Tissue Sarcoma | Resectable Soft Tissue Sarcoma | Adult Soft Tissue Sarcoma

France
National Institute of Allergy and Infectious Diseases...

Recruiting

Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons

Epstein-Barr Virus Infection | Infectious Mononucleosis | Herpesvirus

United States
The University of Texas Medical Branch, Galveston
Cancer Prevention Research Institute of Texas

Recruiting

Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)

HPV Infection | Human Papillomavirus | Immunization

United States
Technische Universität Dresden
Deutsches Krebsforschungszentrum (DKFZ)

Recruiting

Response Prediction of Hyperthermic Intraperitoneal Chemotherapy in Gastro- Intestinal Cancer (Hi-STEP1)

Gastric Cancer | Colon Cancer | Peritoneal Carcinomatosis

Germany
Centre Hospitalier Universitaire de Nice

Recruiting

Immunological Functionnal Test Validation to Predict Melanoma Metastatic Patient Response to Checkpoint Inhibitors (mela-quantif)

Melanoma (Skin)

France
Chinese PLA General Hospital

Recruiting

Neo-adjuvant Chemotherapy Evluation in Gastric Cancer Patients Based on Circulating Exosomal LncRNA-GC1

Gastric Cancer | Chemotherapy Effect

China
University of Kansas Medical Center

Recruiting

Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC (NeoTRACT)

Breast Cancer | Triple Negative Breast Cancer

United States
Royal Marsden NHS Foundation Trust

Recruiting

Exploratory Study of Early Biomarkers Allowing Dynamic Assessment of Response to Treatment in Cancers of the Head and Neck (DART)

Head and Neck Cancer

United Kingdom
Institut Jean-Godinot
Université de Reims Champagne-Ardenne

Not yet recruiting

Association Between Helioderma and Response to Immunotherapy in Patients With Metastatic Melanoma (Helioma)

Metastatic Melanoma
Zhejiang Cancer Hospital

Recruiting

DLCS for Predicting Neoadjuvant Chemotherapy Response

Gastric Cancer | Deep Learning | Neoadjuvant Chemotherapy | CT Images | Tumor Regression Grade

China
Istituto Clinico Humanitas

Recruiting

Contrast Enhanced Harmonic Endoscopic Ultrasound (CH-EUS), Elastography, and Fractal Analysis in Predicting Pancreatic Cancer Aggressiveness and Response to Therapy. (CH-E-EUS)

Pancreatic Mass

Italy
Yongpeng Wang

Recruiting

A Study of Fluzoparib Combined With QL1101 Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

Ovarian Cancer

China
University of Zurich

Recruiting

Response Assessment During MR-guided Radiation Therapy for Glioblastoma (MARGA)

Glioblastoma Multiforme

Switzerland
Hospices Civils de Lyon

Recruiting

Predictive Clinical Features for Response to Adjuvant Immunotherapy in Stage II,III and IV Resected Melanoma (Mel-ImmAdj)

Melanoma

France
Jena University Hospital

Recruiting

Longitudinal Multimodal Response Assessment During Neoadjuvant Treatment of Rectal Cancer (PRIMO)

Radiotherapy | Neoadjuvant Treatment | Locally Advanced Rectal Carcinoma | Adaptive Treatment

Germany
chenwu

Recruiting

Potential Clinical Utilities of Circulating Tumor DNA in Advanced HER2 Negative Gastric Cancer

Gastric Cancer | Circulating Tumor DNA (ctDNA)

China
Erasmus Medical Center

Recruiting

Biomarker Identification of Radionuclide Therapy-induced Radiation Responses (Radio-Marker)

Neuroendocrine Tumors

Netherlands
Peking University Cancer Hospital & Institute

Recruiting

Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma

Melanoma | Temozolomide | Apatinib | Camrelizumab | Acral Melanoma | Neoadjuvant | Pathological Response

China
Henan Provincial People's Hospital

Not yet recruiting

Study on Gene Evolution in Glioma Under Stress Therapy

Genetic Change

China
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors (PIONEER)

Solid Tumor, Adult | Solid Tumor, Childhood | Hematologic Cancer

France
UNC Lineberger Comprehensive Cancer Center
Radiological Society of North America

Recruiting

18-fluorofuranylnorprogesterone (FFNP) PET/MRI as a Potential Biomarker of Response to Progesterone Therapy

Endometrial Cancer | Complex Atypical Hyperplasia

United States
Beijing Tiantan Hospital
Beijing GeneX Health Technology Co., Ltd

Recruiting

PTCs-based Precision Treatment Strategy on Recurrent High-grade Gliomas

Recurrent High Grade Glioma

China
Travera Inc
xCures

Recruiting

Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) (TraveraRTGx)

Melanoma | Carcinoma, Renal Cell | Carcinoma | Carcinoma, Non-Small-Cell Lung | Carcinoma, Hepatocellular | Carcinoma, Pancreatic | Pancreatic Cancer | Mesothelioma | Cholangiocarcinoma | Carcinoma, Neuroendocrine | Carcinoma, Small Cell | Pleural Effusion, Malignant | Carcinoma, Pancreatic Ductal | Carcinoma of the... and other conditions

United States
Centre Hospitalier Alpes Leman

Not yet recruiting

Central Venous Catheter-related Complications in Patients Under Anticancer Treatment (KTcCHO)

Solid Tumor | Central Venous Catheter Thrombosis | Hematologic Malignancy | Central Venous Catheter Related Bloodstream Infection
Assistance Publique - Hôpitaux de Paris

Recruiting

Predictive Markers of Response and Toxicity in Patients With a Haematological Malignancy Treated With Immunotherapy. (PRONOSTIM)

Blood Cancer

France
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)

Sepsis | Septic Shock | Hematologic Malignancy | Tumor | Allogeneic Stem Cell Transplantation
D'Or Institute for Research and Education
HalioDx; Diagnosticos da America SA

Recruiting

Role of Immunoscore® in Stage II-III Colorectal Cancer

Colon Adenocarcinoma

Brazil
Melanoma Institute Australia
Bristol-Myers Squibb

Recruiting

A Phase 2 Clinical Trial of Neoadjuvant Relatlimab and Nivolumab in High Risk, Clinical Stage II Cutaneous Melanoma (Neo ReNi II)

Stage II Melanoma

Australia
Imperial College London
University College London Hospitals; Northern Care Alliance NHS Foundation... and other collaborators

Recruiting

Augmented Response of Volatile Biomarkers in Assessment of Oesophagogastric Cancer (AROMA 1 / BIORESOURCE)

Gastric Cancer | Oesophageal Cancer | Microbiome | Volatile Organic Compounds | Transcriptomics | Microbioata | Breath Analysis | Volatalomics | Metabonomics/Lipidomics | Microbiome Analysis

United Kingdom
Catharina Ziekenhuis Eindhoven
ZonMw: The Netherlands Organisation for Health Research and Development; Stichting... and other collaborators

Recruiting

Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment (PRedICT-TOPIC)

Cervical Intraepithelial Neoplasia | CIN 2/3 | Cervical Intraepithelial Neoplasia Grade 2/3 | Cervical High Grade Squamous Intraepithelial Lesion

Netherlands
Centre Francois Baclesse

Recruiting

Establishment of an ex Vivo Tumor Collection of Triple-negative Breast Cancers in Order to Validate the Interest of Innovative Therapies and the Search for Predictive Biomarkers of Response to Treatment (TRIPLEX)

Triple Negative Breast Cancer | Organoid

France
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Recruiting

Study of Tuvusertib (M1774) in Combination With DNA Damage Response Inhibitor or Immune Checkpoint Inhibitor (DDRiver Solid Tumors 320)

Metastatic or Locally Advanced Unresectable Solid Tumors

United States, Canada, Spain
University of Sulaimani

Recruiting

Therapeutic Response to Tumor Necrosis Factor-alpha (TNF-alpha) Antagonists in Rheumatoid Arthritis. (TNF-alpha)

Rheumatoid Arthritis | Inflammatory Arthritis | Ankylosing Spondylitis

Iraq
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

Merkel Cell Carcinoma | Cutaneous Melanoma | Cutaneous Squamous Cell Carcinoma

United States
Amsterdam UMC, location VUmc
Dutch Cancer Society

Recruiting

Single-dose Preoperative Partial Breast Irradiation in Low-risk Breast Cancer Patients (ABLATIVE-2)

Breast Cancer

Netherlands
Jun Zhang, MD, PhD
Nilogen Oncosystems

Recruiting

Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC (TUMORIN)

NSCLC | Lung Cancer | NSCLC Stage IV

United States
National Cancer Institute (NCI)

Recruiting

M9241 in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer or Intrahepatic Cholangiocarcinoma

Colorectal Neoplasms | Colorectal Cancer | Cholangiocarcinoma | Bile Duct Cancer | Bile Duct Neoplasms | Metastatic Colorectal Cancer (Mcrc) | Intrahepatic Cholangiocarcinoma (Icc) | Intrahepatic Bile Duct Cancer

United States
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France; FONCER contre...

Recruiting

Biomarkers of Angiogenesis for Response to Therapeutic Combination in Advanced or Metastatic Kidney Cancer (ANGIOCOR)

Renal Cell Carcinoma | Renal Cancer | Renal Cancer Metastatic

France
Institut Curie
Merck Sharp & Dohme LLC

Recruiting

Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal MElanoma Patients (PLUME) (PLUME)

Metastatic Uveal Melanoma

France
The Netherlands Cancer Institute

Recruiting

FMT to Convert Response to Immunotherapy

Melanoma Stage IV | Melanoma Stage III

Netherlands
National Cancer Institute (NCI)

Recruiting

Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)

Neuroendocrine Tumors | Carcinoma, Neuroendocrine

United States
Medical University of Silesia
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology,...

Recruiting

The Assessment of Immune Response in Newly Diagnosed Glioblastoma Patients Treated With Pembrolizumab (PIRG)

Newly Diagnosed Glioblastoma

Poland
Children's Oncology Group
National Cancer Institute (NCI)

Recruiting

Evaluation of Immunologic Response Following COVID-19 Vaccination in Children, Adolescents, and Young Adults With Cancer

Malignant Solid Neoplasm | COVID-19 Infection | Hematopoietic and Lymphatic System Neoplasm

United States
Luzerner Kantonsspital
Universität Luzern

Recruiting

Do Markers of Systemic Inflammatory Response and Tumor Metabolism Indicate Radioresistance in Head and Neck Cancer?

Head and Neck Squamous Cell Carcinoma

Switzerland

Search clinical trials for: Tumor Response

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Qatar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations